🇺🇸 FDA
Pipeline program

FT819

FT819-201

Phase 2 mab active

Quick answer

FT819 for Lupus Nephritis is a Phase 2 program (mab) at FATE THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
FATE THERAPEUTICS INC
Indication
Lupus Nephritis
Phase
Phase 2
Modality
mab
Status
active

Clinical trials